Greetings, everyone.  The first complete new week of the New Year was categorized by relatively limited regulatory action, perhaps as everyone got back from the holiday and prepared to launch into the swing of things.  Nevertheless, here are the items of note: FDA Lithium batteries continue their long reach into the affairs of the regulatory…